D
Regeneron Pharmaceuticals, Inc. REGN
$541.69 -$5.98-1.09% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 2.95B 3.61B 3.61B 3.44B 3.03B
Total Other Revenue 81.90M 179.40M 114.20M 104.50M 116.90M
Total Revenue 3.03B 3.79B 3.72B 3.55B 3.15B
Cost of Revenue 1.79B 1.98B 1.76B 1.68B 1.68B
Gross Profit 1.24B 1.81B 1.96B 1.87B 1.46B
SG&A Expenses 633.00M 792.20M 714.40M 758.80M 689.00M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- 14.60M --
Total Operating Expenses 2.42B 2.77B 2.48B 2.45B 2.37B
Operating Income 604.00M 1.02B 1.24B 1.09B 773.80M
Income Before Tax 905.00M 958.10M 1.49B 1.63B 700.70M
Income Tax Expenses 96.30M 40.40M 152.40M 195.80M -21.30M
Earnings from Continuing Operations 808.70M 917.70M 1.34B 1.43B 722.00M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 808.70M 917.70M 1.34B 1.43B 722.00M
EBIT 604.00M 1.02B 1.24B 1.09B 773.80M
EBITDA 730.90M 1.15B 1.37B 1.21B 887.90M
EPS Basic 7.58 8.53 12.40 13.25 6.70
Normalized Basic EPS 4.55 6.97 8.23 7.28 5.33
EPS Diluted 7.27 8.07 11.54 12.41 6.27
Normalized Diluted EPS 4.37 6.59 7.65 6.82 4.99
Average Basic Shares Outstanding 106.70M 107.60M 108.10M 108.10M 107.80M
Average Diluted Shares Outstanding 111.20M 113.80M 116.20M 115.40M 115.10M
Dividend Per Share 0.88 -- -- -- --
Payout Ratio 11.60% -- -- -- --